Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX15 | P16050 | 1/20 | 0.77 |
| ▸ | ACE | P12821 | 3/20 | 0.72 |
| ▸ | ITGB2 | P05107 | 3/20 | 0.69 |
| ▸ | ICAM1 | P05362 | 3/20 | 0.69 |
| ▸ | ITGAL | P20701 | 3/20 | 0.69 |
| ▸ | TACR1 | P25103 | 1/20 | 0.68 |
| ▸ | ECE1 | P42892 | 6/20 | 0.66 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.63 |
| ▸ | APAF1 | O14727 | 1/20 | 0.63 |
| ▸ | POLB | P06746 | 1/20 | 0.63 |
| ▸ | MAPT | P10636 | 1/20 | 0.63 |
| ▸ | RECQL | P46063 | 1/20 | 0.63 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.63 |
| ▸ | FPR2 | P25090 | 1/20 | 0.63 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Acetyltryptophan SCHEMBL1427073 | 1.00 | ALOX15 (0.77) | ALOX15ACEITGB2ICAM1ITGAL | |
| Acetyltryptophan SCHEMBL4216452 | 0.99 | ALOX15 (0.79) | ALOX15ACEITGB2ICAM1ITGAL | |
| Acetyltryptophan SCHEMBL29401158 | 0.99 | ALOX15 (0.79) | ALOX15ACEITGB2ICAM1ITGAL | |
| Acetyltryptophan SCHEMBL4216450 | 0.99 | ALOX15 (0.79) | ALOX15ACEITGB2ICAM1ITGAL | |
| Acetyltryptophan SCHEMBL57141 | 0.99 | ALOX15 (0.79) | ALOX15ACEITGB2ICAM1ITGAL | |
| Acetyltryptophan SCHEMBL702442 | 0.99 | ALOX15 (0.79) | ALOX15ACEITGB2ICAM1ITGAL | |
| Acetyltryptophan SCHEMBL29360698 | 0.99 | ALOX15 (0.79) | ALOX15ACEITGB2ICAM1ITGAL | |
| Acetyltryptophan SCHEMBL57140 | 0.99 | ALOX15 (0.79) | ALOX15ACEITGB2ICAM1ITGAL | |
| Acetyltryptophan SCHEMBL23933298 | 0.97 | ALOX15 (0.77) | ALOX15ACEITGB2ICAM1ITGAL | |
| Acetyltryptophan SCHEMBL11471934 | 0.97 | ALOX15 (0.77) | ALOX15ACEITGB2ICAM1ITGAL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 248 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025126144-A1 | METHODS OF MONITORING PARAMETERS IN SOLUTION | CSL BEHRING AG (CH) | 2025-06-19 | — | — | WO | claimed |
| CN-117420224-B | Method for detecting human serum albumin content in human erythropoietin injection by reversed-phase high performance liquid chromatography | 华北制药金坦生物技术股份有限公司 | 2024-05-07 | — | — | CN | claimed |
| CN-113549653-B | Combination reagent for long-term storage of lentiviral vectors | 上海赛比曼生物科技有限公司 | 2024-03-22 | — | — | CN | claimed |
| CN-117420224-A | Method for detecting human serum albumin content in human erythropoietin injection by reversed-phase high performance liquid chromatography | 华北制药金坦生物技术股份有限公司 | 2024-01-19 | — | — | CN | claimed |
| CN-117397676-A | Cell dehydration drying method and cell dehydration drying preparation prepared by same | 北京朴汇细胞生物科技有限公司 | 2024-01-16 | — | — | CN | claimed |
| CN-117180441-A | Platelet dehydration and drying protective agent, platelet dehydration and drying preparation and preparation method thereof | 北京朴汇细胞生物科技有限公司 | 2023-12-08 | — | — | CN | claimed |
| US-20230141382-A1 | COMPOSITIONS FOR PRESERVATION OF VIRAL VECTORS | AbelZeta Inc. | 2023-05-11 | — | — | US | claimed |
| EP-4139438-A1 | COMPOSITIONS FOR PRESERVATION OF VIRAL VECTORS | Cellular Biomedicine Group Inc. (US) | 2023-03-01 | — | — | EP | claimed |
| WO-2021216989-A1 | COMPOSITIONS FOR PRESERVATION OF VIRAL VECTORS | CELLULAR BIOMEDICINE GROUP HK LIMITED (CN) | 2021-10-28 | — | — | WO | claimed |
| CN-113549653-A | Combination reagents for long-term storage of lentiviral vectors | 上海赛比曼生物科技有限公司 | 2021-10-26 | — | — | CN | claimed |
| CN-113347974-A | Compositions and methods of use of 2- (4-chlorophenyl) -N- ((2- (2, 6-dioxopiperidin-3-yl) -1-oxoisoindolin-5-yl) methyl) -2, 2-difluoroacetamide | 细胞基因公司 | 2021-09-03 | — | — | CN | claimed |
| US-4251510-A | FOR TREATING SHOCK, HYPOPROTEINEMIA | CUTTER LABORATORIES, INC. (US) | 1981-02-17 | — | — | US | claimed |
| JP-6247870-A | — | — | None | — | — | JP | disclosed |
| EP-4739416-A1 | METHOD OF PURIFICATION | CSL Behring AG (CH) | 2026-05-13 | — | — | EP | disclosed |
| US-20260007632-A1 | FORMULATIONS OF DOCETAXEL | ZHUHAI BEIHAI BIOTECH CO LTD (CN) | 2026-01-08 | — | — | US | disclosed |
| US-20250339364-A1 | LIQUID PHARMACEUTICAL COMPOSITION | DAICEL CORPORATION (JP) | 2025-11-06 | — | — | US | disclosed |
| EP-0168008-A2 | Stable composition of gamma-interferon | Takeda Chemical Industries, Ltd. (JP) | 1986-01-15 | — | — | EP | disclosed |
| EP-0158487-A2 | Stable composition of interleukin-2 | Takeda Chemical Industries, Ltd. (JP) | 1985-10-16 | — | — | EP | disclosed |
| US-4378346-A | CONTACTING WITH SILICON DIOXIDE | TANKERSLEY DONALD L | 1983-03-29 | — | — | US | disclosed |
| US-4251510-A | FOR TREATING SHOCK, HYPOPROTEINEMIA | CUTTER LABORATORIES, INC. (US) | 1981-02-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260007632-A1 | FORMULATIONS OF DOCETAXEL | ALB, TTR, SLC20A1 | ALOX15 3575/4885ACE 3975/4885ITGB2 1089/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.